According to the European Cancer Organisation Strategy 2020-2023, our association’s activities are structured around two main pillars:
Activities associated to Pillar 1 (policy and advocacy) are funded according to a range of sources, including membership fees, fees generated by services such as the Accreditation Council of Oncology Education, events, and contributions from sources such as charities and Foundations.
More information on our Strategy 2020-2023 can be found here.
Activities associated to Pillar 2 (convening and facilitating) are supported by ‘Community 365’ industry contributors. Community 365 provides ideas, guidance, practical support and resources for our work in convening stakeholders and building consensus in the European cancer community. More information can be found here.
The European Cancer Organisation is a fully compliant member of the EU Transparency Register (Number 51022176260-12). The transparency register is a database that lists organisations involved in official representations to the law-making and policy implementation process of the EU institutions. The register makes visible what interests are being pursued, by whom, and with what budgets.
As part of its Strategy 2020-23, the European Cancer Organisation has put in place robust governance mechanisms in order to ensure full independence of its policy activities. All policy-making should include clear consultation with our member societies and members of the Patient Advisory Committee with final decision-making by our Board of Directors. Our Board of Directors is comprised of representatives of our Member Societies. The Board of Directors is elected via the General Assembly of members societies. The Board of Directors also includes representation from the Patient Advisory Committee.
For more information see our Process of Policy Decision-Making.